EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study

Francisco Estupiñán-Romero iD, Santiago Royo-Sierra, Javier González-Galindo, Natalia Martínez-Lizaga iD, Petronille Bogaert iD, Nienke Schutte iD, Liesbet Van Eycken, Nancy Van Damme, Kris Henau, Ronan A Lyons, Sarah J Aldridge, Andrea Faragalli iD und 6 weitere

European Journal of Public Health · 2024

DOI: 10.1093/eurpub/ckae038 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Public Health, 2024. Verfasst von Francisco Estupiñán-Romero und 17 weiteren Autor:innen. Beteiligte Einrichtung: Data Science for Health Services and Policy Research, Health Science Institute in Aragon (IACS), Aragon, Spain. Hauptthemen laut MEDLINE: COVID-19, Breast Neoplasms, SARS-CoV-2, Time-to-Treatment. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research and innovation programme, European Union’s Horizon 2020 research and innovation programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The indirect impact of the coronavirus disease 2019 pandemic on healthcare services was studied by assessing changes in the trend of the time to first treatment for women 18 or older who were diagnosed and treated for breast cancer between 2017 and 2021.

Methods

An observational retrospective longitudinal study based on aggregated data from four European Union (EU) countries/regions investigating the time it took to receive breast cancer treatment. We compiled outputs from a federated analysis to detect structural breakpoints, confirming the empirical breakpoints by differences between the trends observed and forecasted after March 2020. Finally, we built several segmented regressions to explore the association of contextual factors with the observed changes in treatment delays.

Results

We observed empirical structural breakpoints on the monthly median time to surgery trend in Aragon (ranging from 9.20 to 17.38 days), Marche (from 37.17 to 42.04 days) and Wales (from 28.67 to 35.08 days). On the contrary, no empirical structural breakpoints were observed in Belgium (ranging from 21.25 to 23.95 days) after the pandemic's beginning. Furthermore, we confirmed statistically significant differences between the observed trend and the forecasts for Aragon and Wales. Finally, we found the interaction between the region and the pandemic's start (before/after March 2020) significantly associated with the trend of delayed breast cancer treatment at the population level.

Conclusions

Although they were not clinically relevant, only Aragon and Wales showed significant differences with expected delays after March 2020. However, experiences differed between countries/regions, pointing to structural factors other than the pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Breast NeoplasmsSARS-CoV-2Time-to-TreatmentHumansFemaleLongitudinal StudiesRetrospective StudiesMiddle AgedPandemicsAdultAgedEuropean UnionPopulation HealthTreatment Delay

Autor:innen und Institutionen

  • Data Science for Health Services and Policy Research, Health Science Institute in Aragon (IACS), Aragon, Spain.
  • Sciensano, Brussels, Belgium.
  • Belgian Cancer Registry, Brussels, Belgium.
  • Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University (SU), Swansea, United Kingdom.
  • Center of Epidemiology Biostatistics and Medical Information Technology, Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche Home, Marche, Italy.
  • Department of Cardiovascular and Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Italy.

ORCID-Profile: Francisco Estupiñán-Romero, Natalia Martínez-Lizaga, Petronille Bogaert, Nienke Schutte, Andrea Faragalli, Luigi Palmieri, Martin Thiβen, Enrique Bernal-Delgado

Förderung

  • European Union's Horizon 2020 research and innovation programme
  • European Union’s Horizon 2020 research and innovation programme

Zitieren

APA

Estupiñán-Romero, F., Royo-Sierra, S., González-Galindo, J., Martínez-Lizaga, N., Bogaert, P., Schutte, N., Van Eycken, L., Van Damme, N., Henau, K., Lyons, R. A., Aldridge, S. J., Faragalli, A., Carle, F., Gesuita, R., Palmieri, L., Misiņš, J., Thiβen, M., & Bernal-Delgado, E. (2024). Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study. European Journal of Public Health. https://doi.org/10.1093/eurpub/ckae038

Vancouver

Estupiñán-Romero F, Royo-Sierra S, González-Galindo J, Martínez-Lizaga N, Bogaert P, Schutte N, et al. Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study. European Journal of Public Health. 2024. doi:10.1093/eurpub/ckae038

BibTeX
@article{EstupinRomero2024,
  author = {Estupiñán-Romero, Francisco and Royo-Sierra, Santiago and González-Galindo, Javier and Martínez-Lizaga, Natalia and Bogaert, Petronille and Schutte, Nienke and Van Eycken, Liesbet and Van Damme, Nancy and Henau, Kris and Lyons, Ronan A and Aldridge, Sarah J and Faragalli, Andrea and Carle, Flavia and Gesuita, Rosaria and Palmieri, Luigi and Misiņš, Jānis and Thiβen, Martin and Bernal-Delgado, Enrique},
  title = {Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study},
  journal = {European Journal of Public Health},
  year = {2024},
  doi = {10.1093/eurpub/ckae038}
}
Kostenlos starten →